Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Palladini · SciRah

Researcher profile · Semantic Scholar

A. Palladini

Share profile

A. Palladini — researcher profile on SciRah

h-index: 21
Works: 82
Citations: 1,422

Most-cited papers

Virus-like particle display of HER2 induces potent anti-cancer responses
A. Palladini, S. Thrane, C. Janitzek, Jessica Pihl +15 more
2018Oncoimmunology104 citations Open access
Semantic Scholar
Multiorgan Metastasis of Human HER-2+ Breast Cancer in Rag2−/−;Il2rg−/− Mice and Treatment with PI3K Inhibitor
P. Nanni, G. Nicoletti, A. Palladini, S. Croci +11 more
2012PLoS ONE90 citations Open access
Semantic Scholar
Activated d16HER2 homodimers and SRC kinase mediate optimal efficacy for trastuzumab.
L. Castagnoli, M. Iezzi, G. Ghedini, V. Ciravolo +14 more
2014Cancer Research81 citations Open access
Semantic Scholar
Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations
P. Nanni, L. Landuzzi, M. Manara, A. Righi +15 more
2019Scientific Reports75 citations Open access
Semantic Scholar
Systemic delivery of HER2-retargeted oncolytic-HSV by mesenchymal stromal cells protects from lung and brain metastases
V. Leoni, Valentina Gatta, A. Palladini, G. Nicoletti +9 more
2015OncoTarget69 citations Open access
Semantic Scholar
Cancer esearch rated Systems and Technologies : Mathematical Oncology ilico Modeling and In vivo Efficacy of R cer-Preventive Vaccinations
A. Palladini, G. Nicoletti, F. Pappalardo, A. Murgo +10 more
201063 citations
Semantic Scholar
The Mechanisms of PD-L1 Regulation in Non-Small-Cell Lung Cancer (NSCLC): Which Are the Involved Players?
G. Lamberti, Monia Sisi, Elisa Andrini, A. Palladini +4 more
2020Cancers54 citations Open access
Semantic Scholar
Preclinical Therapy of Disseminated HER-2+ Ovarian and Breast Carcinomas with a HER-2-Retargeted Oncolytic Herpesvirus
P. Nanni, Valentina Gatta, L. Menotti, C. De Giovanni +10 more
2013PLoS Pathogens53 citations Open access
Semantic Scholar
Gene expression analysis of immune-mediated arrest of tumorigenesis in a transgenic mouse model of HER-2/neu-positive basal-like mammary carcinoma.
A. Astolfi, L. Landuzzi, G. Nicoletti, C. De Giovanni +9 more
2005American Journal of Pathology53 citations Open access
Semantic Scholar
ImmunoGrid: towards agent-based simulations of the human immune system at a natural scale†
M. Halling-Brown, F. Pappalardo, N. Rapin, Ping Zhang +21 more
2010Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences51 citations
Semantic Scholar
Pathobiological implications of the d16HER2 splice variant for stemness and aggressiveness of HER2-positive breast cancer
L. Castagnoli, G. Ghedini, Ada Koschorke, T. Triulzi +11 more
2016Oncogene47 citations Open access
Semantic Scholar
Lipid rafts, caveolae, and epidermal growth factor receptor family: friends or foes?
F. Ruzzi, C. Cappello, M. S. Semprini, L. Scalambra +6 more
2024Cell Communication and Signaling45 citations Open access
Semantic Scholar
Antimetastatic activity of a preventive cancer vaccine.
P. Nanni, G. Nicoletti, A. Palladini, S. Croci +9 more
2007Cancer Research45 citations Open access
Semantic Scholar
Mathematical and Computational Models in Tumor Immunology
F. Pappalardo, A. Palladini, M. Pennisi, F. Castiglione +1 more
201244 citations Open access
Semantic Scholar
Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2
C. De Giovanni, G. Nicoletti, E. Quaglino, L. Landuzzi +13 more
2014Breast Cancer Research43 citations Open access
Semantic Scholar
Virus-like Particle (VLP) Vaccines for Cancer Immunotherapy
F. Ruzzi, M. S. Semprini, L. Scalambra, A. Palladini +5 more
2023International Journal of Molecular Sciences42 citations Open access
Semantic Scholar
ImmunoGrid, an integrative environment for large-scale simulation of the immune system for vaccine discovery, design and optimization
F. Pappalardo, M. Halling-Brown, N. Rapin, Ping Zhang +19 more
2008Briefings Bioinform.42 citations Open access
Semantic Scholar
High metastatic efficiency of human sarcoma cells in Rag2/gammac double knockout mice provides a powerful test system for antimetastatic targeted therapy.
P. Nanni, G. Nicoletti, L. Landuzzi, S. Croci +11 more
2010European Journal of Cancer34 citations
Semantic Scholar
HER2 isoforms co-expression differently tunes mammary tumor phenotypes affecting onset, vasculature and therapeutic response
A. Palladini, G. Nicoletti, A. Lamolinara, M. Dall’Ora +17 more
2017OncoTarget25 citations Open access
Semantic Scholar
IFN-γ and CD38 in Hyperprogressive Cancer Development
Stefania Angelicola, F. Ruzzi, L. Landuzzi, L. Scalambra +5 more
2021Cancers24 citations Open access
Semantic Scholar
Opposing control of rhabdomyosarcoma growth and differentiation by myogenin and interleukin 4
P. Nanni, G. Nicoletti, A. Palladini, A. Astolfi +10 more
2009Molecular Cancer Therapeutics23 citations
Semantic Scholar
Bioprofiling TS/A Murine Mammary Cancer for a Functional Precision Experimental Model
C. De Giovanni, G. Nicoletti, L. Landuzzi, A. Palladini +2 more
2019Cancers21 citations Open access
Semantic Scholar
In silico modeling and in vivo efficacy of cancer-preventive vaccinations.
A. Palladini, G. Nicoletti, F. Pappalardo, A. Murgo +10 more
2010Cancer Research21 citations
Semantic Scholar
Evolution of HER2-positive mammary carcinoma: HER2 loss reveals claudin-low traits in cancer progression
Veronica Giusti, F. Ruzzi, L. Landuzzi, Marianna L. Ianzano +11 more
2021Oncogenesis19 citations Open access
Semantic Scholar
PD-L1 and IFN-γ modulate Non-Small Cell Lung Cancer (NSCLC) cell plasticity associated to immune checkpoint inhibitor (ICI)-mediated hyperprogressive disease (HPD)
Stefania Angelicola, F. Giunchi, F. Ruzzi, M. Frascino +23 more
2025Journal of Translational Medicine16 citations Open access
Semantic Scholar
A Multi-DNA Preventive Vaccine for p53/Neu-Driven Cancer Syndrome
C. De Giovanni, G. Nicoletti, A. Palladini, S. Croci +14 more
2009Human Gene Therapy14 citations
Semantic Scholar
Genomic Landscape, Clinical Features and Outcomes of Non-Small Cell Lung Cancer Patients Harboring BRAF Alterations of Distinct Functional Classes
Alessandro Di Federico, A. De Giglio, F. Gelsomino, D. de Biase +5 more
2022Cancers13 citations Open access
Semantic Scholar
HER Tyrosine Kinase Family and Rhabdomyosarcoma: Role in Onset and Targeted Therapy
C. De Giovanni, L. Landuzzi, A. Palladini, G. Nicoletti +2 more
2021Cells13 citations Open access
Semantic Scholar
Early stability and late random tumor progression of a HER2-positive primary breast cancer patient-derived xenograft
L. Landuzzi, A. Palladini, C. Ceccarelli, S. Asioli +20 more
2021Scientific Reports12 citations Open access
Semantic Scholar
Immune targeting of autocrine IGF2 hampers rhabdomyosarcoma growth and metastasis
C. De Giovanni, P. Nanni, L. Landuzzi, Marianna L. Ianzano +4 more
2019BMC Cancer12 citations Open access
Semantic Scholar
Tumor suppressor genes promote rhabdomyosarcoma progression in p53 heterozygous, HER-2/neu transgenic mice
Marianna L. Ianzano, S. Croci, G. Nicoletti, A. Palladini +9 more
2013OncoTarget12 citations Open access
Semantic Scholar
Targeting PCSK9, through an innovative cVLP-based vaccine, enhanced the therapeutic activity of a cVLP-HER2 vaccine in a preclinical model of HER2-positive mammary carcinoma
L. Scalambra, F. Ruzzi, O. M. Pittino, M. S. Semprini +9 more
2025Journal of Translational Medicine11 citations Open access
Semantic Scholar
Cancer immunoprevention: from mice to early clinical trials
A. Palladini, L. Landuzzi, P. Lollini, P. Nanni
2018BMC Immunology11 citations Open access
Semantic Scholar
Interleukin-15 is required for immunosurveillance and immunoprevention of HER2/neu-driven mammary carcinogenesis
S. Croci, P. Nanni, A. Palladini, G. Nicoletti +10 more
2015Breast Cancer Research11 citations Open access
Semantic Scholar
Genetic prevention of lymphoma in p53 knockout mice allows the early development of p53-related sarcomas
L. Landuzzi, Marianna L. Ianzano, G. Nicoletti, A. Palladini +10 more
2014OncoTarget11 citations Open access
Semantic Scholar
Proteomic and PROTEOMEX profiling of mammary cancer progression in a HER‐2/neu oncogene‐driven animal model system
S. Croci, C. Recktenwald, R. Lichtenfels, G. Nicoletti +9 more
2010Proteomics11 citations
Semantic Scholar
Cancer Vaccines Co-Targeting HER2/Neu and IGF1R
C. De Giovanni, L. Landuzzi, A. Palladini, Marianna L. Ianzano +6 more
2019Cancers10 citations Open access
Semantic Scholar
Human responses against HER-2-positive cancer cells in human immune system-engrafted mice
C. De Giovanni, G. Nicoletti, L. Landuzzi, F. Romani +13 more
2012British Journal of Cancer10 citations Open access
Semantic Scholar
Expression of connective tissue growth factor (CTGF/CCN2) in a mouse model of rhabdomyosarcomagenesis
S. Croci, L. Landuzzi, G. Nicoletti, A. Palladini +4 more
2008Pathology and Oncology Research10 citations
Semantic Scholar
ADK-VR2, a cell line derived from a treatment-naïve patient with SDC4-ROS1 fusion-positive primarily crizotinib-resistant NSCLC: a novel preclinical model for new drug development of ROS1-rearranged NSCLC
F. Ruzzi, Stefania Angelicola, L. Landuzzi, Elena Nironi +14 more
2022Translational Lung Cancer Research9 citations Open access
Semantic Scholar
Prevention and Therapy of Metastatic HER-2+ Mammary Carcinoma with a Human Candidate HER-2 Virus-like Particle Vaccine
F. Ruzzi, A. Palladini, Stine B. Clemmensen, Anette Strøbæk +14 more
2022Biomedicines8 citations Open access
Semantic Scholar
Expression of a functional CCR7 chemokine receptor inhibits the post-intravasation steps of metastasis in malignant murine mammary cancer cells.
S. Croci, G. Nicoletti, L. Landuzzi, A. Palladini +4 more
2007Oncology Report8 citations Open access
Semantic Scholar
Antimetastatic activity of a preventive cancer vaccine (Cancer Research (2007) 67, (11037-11044))
P. Nanni, G. Nicoletti, A. Palladini, S. Croci +9 more
20078 citations Open access
Semantic Scholar
EGFR-RAD51 gene fusion NSCLC responsiveness to different generation EGFR-TKIs: two cases and review of the literature
Alessandro Di Federico, M. Filetti, A. Palladini, R. Giusti +4 more
2021Translational Lung Cancer Research7 citations Open access
Semantic Scholar
OX40 triggering concomitant to IL12-engineered cell vaccine hampers the immunoprevention of HER2/neu-driven mammary carcinogenesis
P. Nanni, C. De Giovanni, Alessia Burocchi, G. Nicoletti +6 more
2018Oncoimmunology7 citations Open access
Semantic Scholar
HER-2/neu tolerant and non-tolerant mice for fine assessment of antimetastatic potency of dendritic cell-tumor cell hybrid vaccines.
L. Landuzzi, A. Antognoli, G. Nicoletti, S. Croci +8 more
2011Vaccine6 citations
Semantic Scholar
Predictive Models in Tumor Immunology
P. Lollini, A. Palladini, F. Pappalardo, S. Motta
20085 citations
Semantic Scholar
Clinical and Preclinical Activity of EGFR Tyrosine Kinase Inhibitors in Non–Small-Cell Lung Cancer Harboring BRAF Class 3 Mutations
Alessandro Di Federico, Stefania Angelicola, M. Frascino, Irene Siracusa +15 more
2024JCO Precision Oncology4 citations Open access
Semantic Scholar
Tamoxifen combined to anti-HER-2/neu cell vaccine does not hamper cancer immunopreventive efficacy.
C. De Giovanni, G. Nicoletti, L. Landuzzi, S. Croci +10 more
2009Vaccine3 citations
Semantic Scholar
Inhibition of prostate carcinogenesis by combined active immunoprophylaxis
C. De Giovanni, S. Croci, G. Nicoletti, L. Landuzzi +10 more
2007International Journal of Cancer3 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

P. Lollini×41
Invite
P. Lollini — researcher profile on SciRah
P. Nanni×39
Invite
P. Nanni — researcher profile on SciRah
L. Landuzzi×36
Invite
L. Landuzzi — researcher profile on SciRah
G. Nicoletti×32
Invite
G. Nicoletti — researcher profile on SciRah

×28

Invite

C. De Giovanni — researcher profile on SciRah

Invite

S. Croci — researcher profile on SciRah

Marianna L. Ianzano×21

Invite

Marianna L. Ianzano — researcher profile on SciRah

Valentina Grosso×13

Invite

Valentina Grosso — researcher profile on SciRah

Invite

M. Iezzi — researcher profile on SciRah

Invite

A. Murgo — researcher profile on SciRah

A. Antognoli×12

Invite

A. Antognoli — researcher profile on SciRah

Invite

F. Ruzzi — researcher profile on SciRah